BOXED O
WARNING O
: O
WARNING O
: O
SECONDARY O
EXPOSURE O
TO O
TESTOSTERONE O
WARNING O
: O
SECONDARY O
EXPOSURE O
TO O
TESTOSTERONE O
* O
Virilization B-OSE_Labeled_AE
has O
been O
reported O
in O
children B-OSE_Labeled_AE
who I-OSE_Labeled_AE
were I-OSE_Labeled_AE
secondarily I-OSE_Labeled_AE
exposed I-OSE_Labeled_AE
to I-OSE_Labeled_AE
testosterone I-OSE_Labeled_AE
gel I-OSE_Labeled_AE
[ O
see O
Warnings O
and O
Precautions O
( O
5.2 O
) O
and O
Adverse O
Reactions O
( O
6.2 O
) O
] O
. O

* O
Children O
should O
avoid O
contact O
with O
unwashed O
or O
unclothed O
application O
sites O
in O
men O
using O
testosterone O
gel O
[ O
see O
Dosage O
and O
Administration O
( O
2.2 O
) O
and O
Warnings O
and O
Precautions O
( O
5.2 O
) O
] O
. O

* O
Healthcare O
providers O
should O
advise O
patients O
to O
strictly O
adhere O
to O
recommended O
instructions O
for O
use O
[ O
see O
Dosage O
and O
Administration O
( O
2.2 O
) O
, O
Warnings O
and O
Precautions O
( O
5.2 O
) O
and O
Patient O
Counseling O
Information O
( O
17 O
) O
] O
. O

EXCERPT O
: O
WARNING O
: O
SECONDARY O
EXPOSURE O
TO O
TESTOSTERONE O
See O
full O
prescribing O
information O
for O
complete O
boxed O
warning O
. O

* O
Virilization O
has O
been O
reported O
in O
children O
who O
were O
secondarily O
exposed O
to O
testosterone O
gel O
. O

( O
5.2 O
, O
6.2 O
) O
* O
Children O
should O
avoid O
contact O
with O
unwashed O
or O
unclothed O
application O
sites O
in O
men O
using O
testosterone O
gel O
. O

( O
2.2 O
, O
5.2 O
) O
* O
Healthcare O
providers O
should O
advise O
patients O
to O
strictly O
adhere O
to O
recommended O
instructions O
for O
use O
. O

( O
2.2 O
, O
5.2 O
, O
17 O
) O

